Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 62 | 1 | 7 | 1 | 750,60 € | 824,47 € | 9,84 % |
| Vertex Pharmaceuticals Inc. | 54 | 2 | 4 | 0 | 461,50 € | 440,93 € | -4,46 % |
| Biogen Inc. | 52 | 1 | 4 | 0 | 196,55 € | 292,88 € | 49,01 % |
| Alnylam Pharmace. | 44 | 0 | 2 | 0 | 219,00 € | 253,95 € | 15,96 % |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 4 | 0 | 996,40 € | 1.034,6 € | 3,84 % |
| Insmed Inc. | 42 | 0 | 9 | 0 | 68,00 € | 75,67 € | 11,28 % |
| Johnson & Johnson | 40 | 1 | 5 | 0 | 148,12 € | 187,15 € | 26,35 % |
| Neurocrine Bioscience | 35 | 0 | 4 | 0 | 134,75 € | 143,34 € | 6,38 % |
| Cytokinetics Inc. | 34 | 1 | 0 | 0 | 54,50 € | 83,92 € | 53,97 % |
| Intra-Cellular Therapies Inc. | 31 | 0 | 1 | 0 | 74,00 € | 83,92 € | 13,41 % |
| AbbVie Inc. | 31 | 0 | 7 | 0 | 171,08 € | 176,90 € | 3,40 % |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | 115,60 € | 124,97 € | 8,11 % |
| Acadia Pharmaceuticals | 29 | 1 | 2 | 0 | 17,53 € | 31,28 € | 78,44 % |
| Pfizer Inc. | 29 | 4 | 2 | 0 | 28,30 € | 41,29 € | 45,92 % |
| Amgen Inc. | 25 | 0 | 2 | 0 | 308,80 € | 304,65 € | -1,35 % |
| United Therapeutics | 24 | 0 | 3 | 0 | 310,20 € | 299,42 € | -3,48 % |
| Ultragenyx Pharmaceutical Inc. | 23 | 1 | 1 | 0 | 41,60 € | 86,28 € | 107,40 % |
| Zoetis Inc. A | 23 | 1 | 0 | 0 | 166,44 € | 200,06 € | 20,20 % |
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | 47,32 € | 56,86 € | 20,16 % |
| Sutro Biopharma Inc | 21 | 0 | 0 | 0 | 3,52 € | 11,04 € | 213,70 % |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 2 | 0 | 9,48 € | 27,83 € | 193,64 % |
| Exelixis Inc. | 20 | 0 | 2 | 0 | 21,50 € | 26,01 € | 20,96 % |
| G1 Therapeutics | 21 | 1 | 0 | 0 | 3,64 € | 10,54 € | 189,81 % |
| Iovance Biotherapeutics Inc. | 22 | 2 | 1 | 0 | 9,15 € | 26,25 € | 186,91 % |
| Natural Alternat. | 21 | 1 | 3 | 0 | 5,05 € | - | - |